logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025

También te puede interesar

Compartir
copy

Ganadores

Últimas noticias sobre criptomonedas

17:49

Trump Says Fed Chair Should Cut Interest Rates, Reiterates Criticism of Powell

17:25

In the past 24 hours, the entire network liquidated $376 million, with the majority coming from the largest short position

17:23

The probability of a 25 basis point interest rate cut by the Federal Reserve in December is currently at 87.2%.

17:21

Trump: Will Announce New Fed Chair in Early Next Year

17:19

Coinbase International Site to Launch DASH Perpetual Contract Trading

Leer más
Comunitario
icon
icon
icon
icon
icon
icon
icon

Atención al cliente@weikecs

Cooperación empresarial@weikecs

Trading cuantitativo y MM[email protected]

Programa VIP[email protected]